Skip to nav Skip to content
  • Cancer Type: Head & Neck
  • Study Type: Treatment
  • NCT#: NCT07281417
  • Phase: Phase II
Learn More
  • Overview

    Study Title:

    Neoadjuvant Chemotherapy with or without Cemiplimab (REGN2810) in Sinonasal Squamous Cell Carcinoma: A Randomized Phase 2 Study

  • Treatments

    Therapies:

    Chemotherapy (NOS); Monoclonal anti-PD-1 Antibody; Radiotherapy

    Medications:

    Cemiplimab (); Paraplatin (carboplatin); REGN2810 (Cemiplimab); Radiotherapy (); Taxol (paclitaxel); carboplatin (); cisplatin (); paclitaxel ()

If you are interested in learning more about clinical trials, our clinical trial navigators can discuss your options and recommend opportunities that may be suitable for you. Call 813-745-6100 or 1-800-679-0775 (toll-free) or submit a clinical trials inquiry form.

Clinical Trial Search